Previous 10 | Next 10 |
Gainers: Aphria (NYSE: APHA ) +36% . Natural Grocers by Vitamin Cottage (NYSE: NGVC ) +33% . BlackLine (NASDAQ: BL ) +29% . Regional Health Properties (NYSEMKT: RHE ) +22% . Griffon Corporation (NYSE: GFF ) +20% . PC Connection (NASDAQ: CNXN ) +19% . Pinterest (NYSE: PINS ) +1...
Acorda Therapeutics ( ACOR -43.7% ) slumps on more than double normal volume after reporting Q2 results after the close yesterday. More news on: Acorda Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Acorda Therapeutics, Inc. (ACOR) Q2 2019 Earnings Conference Call August 01, 2019, 04:30 PM ET Company Participants Felicia Vonella - Executive Director, IR Ron Cohen - CEO Lauren Sabella - CCO David Lawrence - CTO, Chief of Business Operations & Principal Accounting Office...
Acorda Therapeutics (NASDAQ: ACOR ): Q2 Non-GAAP EPS of -$0.55 beats by $0.51 ; GAAP EPS of -$0.58 beats by $0.68 . More news on: Acorda Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
INBRIJA™ (levodopa inhalation powder) 2Q 2019 net sales of $3.0 million CHMP issues positive opinion on INBRIJA AMPYRA ® (dalfampridine) 2Q 2019 net sales of $44.0 million Acorda Therapeutics, Inc. (NASDAQ: ACOR ) provided a financial and pipeline update for the...
ACA , ACOR , AIV , ALEX , ANET , APHA , BFAM , BGS , BIO , BL , BLDR , BMRN , BRKR , BRKS , BZH , CATM , CBLK , CC , CENT , CENX , CERS , CORT , CRC , CWK , CWST , DLB , DVA , EBS , ECOL , ED , ENSG , EOG , ERII , ETSY , FBHS , FLDM , FLR , FND , FRT , ...
Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending INBRIJA’s approval by the European Commission (EC). The recommended indication is: Inb...
Acorda Therapeutics ( ACOR ) is in an unfavorable position with its (now former) main product Ampyra now a generic, the main existing asset Inbrija just entering the market and the company expected to burn a significant amount of cash in the following quarters. To further complicate matters ...
Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast to report its second quarter 2019 update and financial results on Thursday, August 1 at 4:30 p.m. ET. To participate in the conference call, please dial (866) 393-4306 (domestic) or (734) 385-2616 (internatio...
Acorda Therapeutics ( ACOR ) has had a difficult year with the genericization of their AMPYRA asset coming from a court decision in September 2018. The company has lost over half of its equity value YTD and investors have been continually selling shares even amidst a strong bull market. Howe...
News, Short Squeeze, Breakout and More Instantly...
Acorda Therapeutics Inc. Company Name:
ACOR Stock Symbol:
NASDAQ Market:
Acorda Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 11.3% to $0.2025 on volume of 40,515,259 shares Rallybio Corporation (RLYB) rose 80.4% to $2.9401 on volume of 39,492,767 shares Trio Petroleum Corp. (TPET) rose 36.3% to $0.2499 on volume of 3...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 28.8% to $0.0515 on volume of 62,068,605 shares Laser Photonics Corporation (LASE) rose 172.7% to $3.9 on volume of 54,588,758 shares WiSA Technologies Inc. (WISA) fell 6.1% to $0.0217 on volume of 2...
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announc...